RECURRENT WHO GRADE 3 GLIOMA

Clinical trials for RECURRENT WHO GRADE 3 GLIOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT WHO GRADE 3 GLIOMA trials appear

Sign up with your email to follow new studies for RECURRENT WHO GRADE 3 GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1

Early trial aims to halt return of aggressive brain tumors

Disease control Ongoing

This early-stage study is testing a new drug combination for adults whose aggressive brain cancer (glioblastoma) has returned. Researchers want to find the safest and most effective dose of an experimental drug called triapine when given with the standard chemotherapy temozolomid…

Matched conditions: RECURRENT WHO GRADE 3 GLIOMA

Phase: PHASE1 • Sponsor: Northwestern University • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

RECURRENT WHO GRADE 3 GLIOMA

Get alerted when new RECURRENT WHO GRADE 3 GLIOMA trials appear

Early trial aims to halt return of aggressive brain tumors